These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 16732904
1. [Dynamic variations of hepatitis B virus polymerase gene in lamivudine-treated hepatitis B patients]. Feng B, Wei L, Chen M, Han FZ, Wang LP. Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):327-30. PubMed ID: 16732904 [Abstract] [Full Text] [Related]
2. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B. Feng B, Wei L, Chen M, Wang L. Microbiol Res; 2008 May; 163(4):487-92. PubMed ID: 17317127 [Abstract] [Full Text] [Related]
3. [Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment]. Liang WF, Yang DH, Shen YH, Xie YJ, Zhao NF. Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):302-4. PubMed ID: 12773248 [Abstract] [Full Text] [Related]
4. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine. Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Kobayashi M, Ikeda K, Miyakawa Y, Kumada H. J Med Virol; 2004 Oct; 74(2):361-6. PubMed ID: 15332287 [Abstract] [Full Text] [Related]
5. [Detection of the mutation in HBV polymerase gene by RFLP PCR method in hepatitis B patients treated with lamivudine]. Li Z, Guo YB, Hao W, Lin ZH, Jin HY, Liu DG. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):266-9. PubMed ID: 15340574 [Abstract] [Full Text] [Related]
6. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping. Ohishi W, Shirakawa H, Kawakami Y, Kimura S, Kamiyasu M, Tazuma S, Nakanishi T, Chayama K. J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758 [Abstract] [Full Text] [Related]
7. PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine. Yang DH, Liang WF, Xie YJ, Zhao NF, Fan J. Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):232-7. PubMed ID: 14612274 [Abstract] [Full Text] [Related]
8. [Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine]. Pan XP, Wo JE, Chen Z, Chen F, Liang WF, Liu KZ. Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):616-8. PubMed ID: 14572341 [Abstract] [Full Text] [Related]
9. Detection of hepatitis B virus polymerase variations resistant to lamivudine therapy. Zhang X, Han Y, Lu Z, Zhang D, Cai Y. Chin Med J (Engl); 2000 May; 113(5):455-7. PubMed ID: 11776105 [Abstract] [Full Text] [Related]
10. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences. Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S. J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034 [Abstract] [Full Text] [Related]
11. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection. Ramezani A, Velayati AA, Roshan MR, Gachkar L, Banifazl M, Keyvani H, Aghakhani A. Int J Infect Dis; 2008 May; 12(3):252-5. PubMed ID: 17954033 [Abstract] [Full Text] [Related]
12. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients]. Shin YM, Heo J, Kim GH, Kang DH, Song GA, Cho M, Yang US, Kim CM, Park HK, Jang HJ. Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):1-9. PubMed ID: 12657823 [Abstract] [Full Text] [Related]
13. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B. Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM. Antivir Ther; 2006 Mar; 11(4):447-55. PubMed ID: 16856618 [Abstract] [Full Text] [Related]
14. [A study on the mutation of P gene region including YMDD motif in hepatitis B virus]. Feng B, Wei L, Chen M, Li XH. Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):29-31. PubMed ID: 14761279 [Abstract] [Full Text] [Related]
15. [A study on detection method of lamivudine related mutations in hepatitis B virus polymerase gene]. Ding JJ, Zhang WS, Zhang LS. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):24-7. PubMed ID: 15340520 [Abstract] [Full Text] [Related]
16. [Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance]. Hu YY, Jiang JJ, Li D, Lin CW, Li QG, Chen Y. Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):427-30. PubMed ID: 12890350 [Abstract] [Full Text] [Related]
17. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B. Chen JY, Wang LW, Sun XM, Gong ZJ. Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):393-7. PubMed ID: 16109523 [Abstract] [Full Text] [Related]
18. [Mutations of HBV polymerase gene sequence in lamivudine-resistant chronic hepatitis B patients]. Wang C, Sun J, Chen JJ, Wang ZH, Hou JL. Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):729-30. PubMed ID: 18504191 [Abstract] [Full Text] [Related]
19. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation]. Deng H, Lv Y, Fu J. Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):368-9. PubMed ID: 15225437 [Abstract] [Full Text] [Related]
20. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine. Amini-Bavil-Olyaee S, Hosseini SY, Sabahi F, Alavian SM. Int J Infect Dis; 2008 Jan; 12(1):83-7. PubMed ID: 17698384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]